Liu Y - Search Results

1

Triple negative breast cancer therapy with CDK1 siRNA delivered by cationic lipid assisted PEG-PLA nanoparticles.

Liu Y, Zhu YH, Mao CQ, Dou S, Shen S, Tan ZB, Wang J. Liu Y, et al. J Control Release. 2014 Oct 28;192:114-21. doi: 10.1016/j.jconrel.2014.07.001. Epub 2014 Jul 10. J Control Release. 2014. PMID: 25016158

2

Targeting glucose uptake with siRNA-based nanomedicine for cancer therapy.

Xu CF, Liu Y, Shen S, Zhu YH, Wang J. Xu CF, et al. Among authors: liu y. Biomaterials. 2015 May;51:1-11. doi: 10.1016/j.biomaterials.2015.01.068. Epub 2015 Feb 16. Biomaterials. 2015. PMID: 25770992

3

Co-delivery of platinum drug and siNotch1 with micelleplex for enhanced hepatocellular carcinoma therapy.

Shen S, Sun CY, Du XJ, Li HJ, Liu Y, Xia JX, Zhu YH, Wang J. Shen S, et al. Among authors: liu y. Biomaterials. 2015 Nov;70:71-83. doi: 10.1016/j.biomaterials.2015.08.026. Epub 2015 Aug 17. Biomaterials. 2015. PMID: 26302232

4

Tumor Acidity-Sensitive Polymeric Vector for Active Targeted siRNA Delivery.

Sun CY, Shen S, Xu CF, Li HJ, Liu Y, Cao ZT, Yang XZ, Xia JX, Wang J. Sun CY, et al. Among authors: liu y. J Am Chem Soc. 2015 Dec 9;137(48):15217-24. doi: 10.1021/jacs.5b09602. Epub 2015 Nov 25. J Am Chem Soc. 2015. PMID: 26571079

5

Restoring anti-tumor functions of T cells via nanoparticle-mediated immune checkpoint modulation.

Li SY, Liu Y, Xu CF, Shen S, Sun R, Du XJ, Xia JX, Zhu YH, Wang J. Li SY, et al. Among authors: liu y. J Control Release. 2016 Jun 10;231:17-28. doi: 10.1016/j.jconrel.2016.01.044. Epub 2016 Jan 29. J Control Release. 2016. PMID: 26829099

6

Tumor acidity-sensitive linkage-bridged block copolymer for therapeutic siRNA delivery.

Xu CF, Zhang HB, Sun CY, Liu Y, Shen S, Yang XZ, Zhu YH, Wang J. Xu CF, et al. Among authors: liu y. Biomaterials. 2016 May;88:48-59. doi: 10.1016/j.biomaterials.2016.02.031. Epub 2016 Feb 23. Biomaterials. 2016. PMID: 26945455

7

Targeting glucose uptake of glioma cells by siRNA delivery with polymer nanoparticle.

Xu CF, Liu Y, Shen S, Zhu YH, Wang J. Xu CF, et al. Among authors: liu y. J Control Release. 2015 Sep 10;213:e23-4. doi: 10.1016/j.jconrel.2015.05.035. Epub 2015 Aug 19. J Control Release. 2015. PMID: 27005134 No abstract available.

8

Cancer stem cell therapy using doxorubicin conjugated to gold nanoparticles via hydrazone bonds.

Sun TM, Wang YC, Wang F, Du JZ, Mao CQ, Sun CY, Tang RZ, Liu Y, Zhu J, Zhu YH, Yang XZ, Wang J. Sun TM, et al. Among authors: liu y. Biomaterials. 2014 Jan;35(2):836-45. doi: 10.1016/j.biomaterials.2013.10.011. Epub 2013 Oct 18. Biomaterials. 2014. PMID: 24144908

9

Synthetic lethal therapy for KRAS mutant non-small-cell lung carcinoma with nanoparticle-mediated CDK4 siRNA delivery.

Mao CQ, Xiong MH, Liu Y, Shen S, Du XJ, Yang XZ, Dou S, Zhang PZ, Wang J. Mao CQ, et al. Among authors: liu y. Mol Ther. 2014 May;22(5):964-73. doi: 10.1038/mt.2014.18. Epub 2014 Feb 5. Mol Ther. 2014. PMID: 24496383 Free PMC article.

10

Cationic lipid-assisted polymeric nanoparticle mediated GATA2 siRNA delivery for synthetic lethal therapy of KRAS mutant non-small-cell lung carcinoma.

Shen S, Mao CQ, Yang XZ, Du XJ, Liu Y, Zhu YH, Wang J. Shen S, et al. Among authors: liu y. Mol Pharm. 2014 Aug 4;11(8):2612-22. doi: 10.1021/mp400714z. Epub 2014 Feb 20. Mol Pharm. 2014. PMID: 24521262

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209,998 results

Search Page

Filters